Nifty
Sensex
:
:
13258.55
45079.55
124.65 (0.95%)
446.90 (1.00%)

Pharmaceuticals & Drugs - Global

Rating :
38/99  (View)

BSE: Not Listed | NSE: ZOTA

141.80
0.30 (0.21%)
04-Dec-2020 | 3:44PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  144.80
  •  145.00
  •  141.00
  •  141.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  8849
  •  12.55
  •  206.40
  •  121.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 348.27
  • 133.08
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 347.43
  • 0.71%
  • 4.95

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.93%
  • 1.11%
  • 26.13%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 2.83%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 8.00
  • 6.91

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -13.88
  • -15.98

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -11.59
  • -27.59

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
28
25
11%
18
22
-19%
23
21
12%
25
22
15%
Expenses
27
24
14%
16
21
-21%
22
19
14%
24
22
13%
EBITDA
1
1
-40%
1
1
35%
2
2
-8%
1
0
181%
EBIDTM
3%
6%
7%
4%
7%
8%
3%
1%
Other Income
0
0
-45%
0
0
-23%
1
0
43%
0
0
82%
Interest
0
0
100%
0
0
0%
0
0
0%
0
0
0%
Depreciation
1
0
141%
1
0
147%
1
0
285%
0
0
30%
PBT
1
1
-10%
1
1
-24%
1
2
-41%
1
0
980%
Tax
0
0
-19%
0
0
-54%
0
1
-46%
0
0
-
PAT
1
1
-7%
1
1
-9%
1
1
-38%
0
0
36%
PATM
4%
4%
3%
3%
3%
6%
2%
1%
EPS
0.41
0.45
-9%
0.21
0.23
-9%
0.29
0.47
-38%
0.15
0.11
36%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Net Sales
94
95
86
Net Sales Growth
5%
11%
 
Cost Of Goods Sold
64
66
57
Gross Profit
30
29
29
GP Margin
32%
30%
33%
Total Expenditure
90
91
78
Power & Fuel Cost
-
1
1
% Of Sales
-
1%
1%
Employee Cost
-
10
8
% Of Sales
-
10%
9%
Manufacturing Exp.
-
2
2
% Of Sales
-
2%
2%
General & Admin Exp.
-
6
6
% Of Sales
-
7%
6%
Selling & Distn. Exp.
-
6
4
% Of Sales
-
6%
5%
Miscellaneous Exp.
-
0
0
% Of Sales
-
0%
0%
EBITDA
4
5
8
EBITDA Margin
5%
5%
9%
Other Income
1
2
2
Interest
0
0
0
Depreciation
3
2
1
PBT
4
4
8
Tax
1
1
2
Tax Rate
25%
29%
29%
PAT
3
3
6
PAT before Minority Interest
3
3
6
Minority Interest
0
0
0
PAT Margin
3%
3%
6%
PAT Growth
-15%
-51%
 
EPS
1.07
1.11
2.26

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Shareholder's Funds
69
69
Share Capital
25
18
Total Reserves
44
51
Non-Current Liabilities
1
1
Secured Loans
0
0
Unsecured Loans
0
0
Long Term Provisions
1
1
Current Liabilities
19
20
Trade Payables
15
16
Other Current Liabilities
2
1
Short Term Borrowings
0
0
Short Term Provisions
2
3
Total Liabilities
88
90
Net Block
15
10
Gross Block
28
20
Accumulated Depreciation
13
11
Non Current Assets
30
27
Capital Work in Progress
0
2
Non Current Investment
14
16
Long Term Loans & Adv.
0
0
Other Non Current Assets
0
0
Current Assets
59
62
Current Investments
0
0
Inventories
25
33
Sundry Debtors
29
22
Cash & Bank
1
2
Other Current Assets
4
3
Short Term Loans & Adv.
3
4
Net Current Assets
40
43
Total Assets
88
90

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Cash From Operating Activity
6
-3
PBT
4
8
Adjustment
1
0
Changes in Working Capital
2
-9
Cash after chg. in Working capital
7
-1
Interest Paid
0
0
Tax Paid
-1
-2
Other Direct Exp. Paid
0
0
Extra & Other Items
0
0
Cash From Investing Activity
-4
9
Net Fixed Assets
-6
Net Investments
2
Others
1
Cash from Financing Activity
-3
-6
Net Cash Inflow / Outflow
-1
-1
Opening Cash & Equivalents
2
2
Closing Cash & Equivalent
1
2

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Book Value (Rs.)
28
28
ROA
3%
6%
ROE
4%
8%
ROCE
6%
11%
Fixed Asset Turnover
3.93
4.21
Receivable days
98
94
Inventory Days
111
139
Payable days
71
72
Cash Conversion Cycle
138
160
Total Debt/Equity
0.00
0.00
Interest Cover
57
214

News Update


  • Zota Health Care gets renewal of ‘License to work factory’ for Surat plant
    13th Nov 2020, 11:28 AM

    The aforementioned factory license is valid up to December 31, 2023

    Read More
  • Zota Health Care gets renewal of letter of approval from Development Commissioner, Surat
    10th Sep 2020, 10:43 AM

    The Company has received the Letter of Approval for the period of five years

    Read More
  • Zota Health Care to launch new store segment ‘Davaindia Ayurveda & Wellness’
    4th Sep 2020, 16:31 PM

    To give business opportunity to all those business aspirants, the company has decided to launch a new store

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.